Matrix metalloproteinases and their tissue inhibitors in endocrinology

Trends in Endocrinology and Metabolism

Volumn 7, Issue 1, 1996, Pages 28-34

  Salamonsen, Lois A ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; COLLAGENASE; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; FOLLITROPIN; GELATINASE; GLUCOCORTICOID; GROWTH FACTOR; INTERLEUKIN 1; KALLIKREIN; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; MITOGENIC AGENT; PARATHYROID HORMONE; PROGESTERONE; RETINOID; SOMATOMEDIN BINDING PROTEIN 3; STEROID HORMONE; STROMELYSIN; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; CARCINOGENESIS; DIABETES MELLITUS; ENDOCRINE DISEASE; ENZYME REGULATION; FIBROSIS; HORMONAL REGULATION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NIDATION; NONHUMAN; OVARY CANCER; OVULATION; PRIORITY JOURNAL; RAT; REPRODUCTION; SHORT SURVEY;

EID: 0030022027     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-2760(95)00189-1     Document Type: Short Survey

References (49)

1. Baricos WH: 1995. Chronic renal disease: do metalloproteinase inhibitors have a demonstrable role in extracellular matrix accumulation? Curr Opin Nephrol Hypertens 4:365-368.
2. Barrett AJ: 1995. Proteolytic enzymes: aspartic and metallopeptidases. Methods Enzymol 248:413-528.
3. Birkedal-Hansen H, Moore WGI, Bodden MK, et al.: 1993. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250.
4. Boujrad N, Ogwuegbu SO, Garnier M, Lee C-H, Martin BM, Papadopoulos V: 1995. Identification of a stimulator of steroid hormone synthesis isolated from testis. Science 268:1609-1612.
5. Brown D, Hamdi H, Bahn S, Kenney MC 1994. Characterization of an endogenous metalloproteinase in human vitreous. Curr Eye Res 13:639-647.
6. Cao J, Sato H, Takino T, Seiki M: 1995. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270:801-805.
7. Cross JC, Werb Z, Fisher SJ: 1994. Implantation and the placenta: key pieces of the development puzzle. Science 266:1508-1518.
8. De Clerck YA, Shimada H, Taylor SM, Langley KE: 1994. Matrix metalloproteinases and their inhibitors in tumor progression. Ann NY Acad Sci 732:222-232.
9. Delaissé JM, Vaes G: 1992. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In Rifkin BR, Gay GV, eds. Biology and Physiology of the Osteoclast. Boca Raton, FL, CRC Press, pp 289-314.
10. Delany AM, Brinckerhoff CE: 1992. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Biochem 50:400-410.
11. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: 1993. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59:329-341.
12. Diekmann O, Tschesche H: 1994. Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix metalloproteinases MMP 8 and MMP 9. Braz J Med Biol Res 27:1865-1876.
13. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H: 1994. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269:25,742-25,746.
14. Freije JMP, Diez-Itza I, Balbin M, et al.: 1994. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269:16,766-16,773.
15. Gearing AJH, Beckett P, Christodoulou M: 1995. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555-557.
16. Hampton and Salamonsen: 1994. Expression of messenger RNA encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 14: R1-R3.
17. Harper J, Harper E: 1987. Insulin stimulates secretion of a collagenase inhibitor by swarm rat chondrosarcoma chondrocytes. Biochem Biophys Res Commun 147:550-555.
18. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A: 1994. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 107:2372-2379.
19. Imada K, Ito A, Itoh Y, Nagase H, Mori Y: 1994. Progesterone increases the production of tissue inhibitor of metalloproteinases-2 in rabbit uterine cervical fibroblasts. FEBS Lett 341:109-112.
20. Jeffrey JJ: 1991. Collagen and collagenase: pregnancy and parturition. Semin Perinatol 15:118-126.
21. Jeziorska M, Salamonsen LA, Woolley DE: 1995. Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod 53:312-320.
22. Kishani NS, Staskus PW, Yang T-T, Masiarz FR, Hawkes SP: 1994. Identification and characterization of human tissue inhibitor of metalloproteinases and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix Biol 14:479-488.
23. Kleiner DE, Stetler-Stevenson, WG: 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Analyt Biochem 218:325-329.
24. Krane SM: 1993. Some molecular mechanisms of glucocorticoid action. Br J Rheumatol 32(Suppl 2):3-5.
25. Lopez-Barahona M, Fialka I, Gonzalez-Sancho JM, et al.: 1995. Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J 14:1145-1155.
26. Marbaix E, Kokorine I, Henriet P, Donnez J, Courtoy PJ, Eeckhout Y: 1995. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J 305:1027-1030.
27. Matrisian LM, Hogan BLM: 1990. Growth factor regulated proteases and extracellular matrix remodeling during mammalian de velopment. In Nilsen-Hamilton M, ed. Growth Factors and Development: Current Topics in Developmental Biology. San Diego, Academic Press, pp 219-259.
28. McGeehan GM, Becherer JD, Bast RC Jr: 1994. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370:558-561.
29. McLennan SV, Fisher EJ, Yue DK, Turtle JR: 1994. High glucose concentration causes a decrease in mesangium degradation: a factor in the pathogenesis of diabetic nephropathy. Diabetes 43:1041-1045.
30. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson W, Zucker S: 1992. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect Tissue Res 28:213-230.
31. Nagle RB, Knox JD, Wolf C, Bowden GT, Cress AE: 1994. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem (Suppl 19):232-237.
32. Naylor MS, Stamp GW, Davies BD, Balkwill FR: 1994. Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58:50-56.
33. Polette M, Gilbert N, Stas I, et al.: 1994. Gelatinase A expression and localization in human breast cancers: an in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Arch 424:641-645.
34. Rechberger T, Woessner JF: 1993. Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am J Obstet Gynecol 168:1598-1603.
35. Rodgers WH, Matrisian LM, Giudice LC, et al.: 1994. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94:946-953.
36. Russell DL, Findlay JK. 1995 The N-terminal peptide of the inhibin a-subunit: what are the endocrine and paracrine roles? Trends Endocrin Metabol 6:305-311.
37. Russell DL, Salamonsen LA, Findlay JK: 1995. Immunization against the N-terminal peptide of the inhibin a43-subunit (αN) disrupts tissue remodeling and the increase in matrix metalloproteinase-2 during ovulation. Endocrinology 136:3657-3664.
38. Salamonsen LA: 1994. Matrix metalloproteinases and endometrial remodelling. Cell Biol Int 18:1139-1144.
39. Salamonsen LA, Nagase H, Woolley DE: 1995. Matrix metalloproteinases and their tissue inhibitors at the ovine trophoblastuterine interface. J Reprod Fertil Suppl 49: 29-37.
40. Salvesen G, Nagase H: 1989. Inhibition of proteolytic enzymes. In Beynon RJ, Bond JS, eds. Proteolytic Enzymes, A Practical Approach. Oxford, IRL Press, pp 83-104.
41. Schaefer L, Schaefer RM, Ling H, Teschner M, Heidland, A: 1994. Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 37:567-571.
42. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573.
43. Tadakuma H, Okamura H, Kitaoka M, Iyama K, Usuku G: 1993. Association of immunolocalization of matrix metalloproteinase 1 with ovulation in hCG-treated rabbit ovary. J Reprod Fertil 98:503-508.
44. Talhouk RS, Werb Z, Bissell MJ: 1992. Functional interplay between extracellular matrix and extracellular matrix-degrading proteinases in the mammary gland: a coordinate system for regulating mammary epithelial function. In Fleming TP, ed. Epithelial Organization and Development. London, Chapman & Hall, pp 329-352.
45. Tsafriri A, Dekel N: 1994. Molecular mechanisms in ovulation. In Findlay JK, ed. Molecular Biology of the Female Reproductive System. London, Academic Press, pp 207-258.
46. Ulisse S, Farina AR, Piersanti D, et al.: 1994. Follicle-stimulating hormone increases the expression of tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 and induces TIMP-1 AP-1 site binding complex(es) in prepubertal rat Sertoli cells. Endocrinology 135:2479-2487.
47. Weber KT, Sun Y, Guarda E: 1994. Structural remodeling in the hypertensive heart disease and the role of hormones. Hypertension 23:869-877.
48. 1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 269:18,953-18,960.
49. Wolf C, Rouyer N, Lutz Y, et al.: 1993. Stromelysin-3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90:1843-1847.